Fangyuan Hao

1 ta ish

Regend Therapeutics (China)

1. Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial

   Shiqi Li, Sikai Ling, Dawei Wang +17

   Maqola20245 iqtibos

   ABIABI:AkademIndex/2026.other.312835